Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not directly trigger menstruation. There is no mechanism in tirzepatide that acts on the uterine lining or the hormonal cascade that produces a period. That said, several women do report cycle changes after starting treatment, and there are real biological reasons why this might happen — even if the pen itself isn't the cause. These are prescription-only medicines; any significant or unexplained change in your cycle is worth discussing with a clinician rather than attributing to the drug alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching this question aren't asking about pharmacology. They've noticed something (a period arriving earlier than expected, a heavier bleed than usual, or a cycle returning after months of nothing) and they want to know whether the pen in their fridge is responsible. That uncertainty is understandable, and the honest answer is: probably not the drug directly, but possibly the drug's effects indirectly.
Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) to reduce appetite and slow gastric emptying. It has no oestrogen, no progesterone, no pituitary action. The NHS tirzepatide medicines page lists the known side effects in detail; menstrual irregularity appears in the prescribing information as an uncommon effect, thought to be secondary to weight change rather than a direct drug action. The pen doesn't reach into your hypothalamus and flip a switch, but your hypothalamus does respond to changes in body fat, and that's where this gets interesting.
So the decision isn't really "should I stop Mounjaro because of my cycle". It's "should I get this assessed". For most women, the answer to the second question is yes, because a returning or shifting cycle can carry real implications, especially for contraception.
Fat tissue is metabolically active. It stores and converts hormones, particularly oestrogens. When body weight falls, that storage changes, and the hypothalamic-pituitary-ovarian axis (the hormonal relay that governs ovulation and menstruation) can shift in response. Women with polycystic ovary syndrome (PCOS) or obesity-related amenorrhoea sometimes find that significant weight loss restores cycle regularity they hadn't seen in years. That is generally a positive sign, but it can feel alarming if you weren't expecting it.
The same process can work in the other direction for a small number of women: rapid early weight loss and caloric restriction can temporarily disrupt the axis, causing a delayed or lighter period. Neither outcome means something is wrong with the medicine. Both mean your body is responding to a shift in energy balance.
You can read more about how these cycle changes connect to broader hormonal questions on our Mounjaro and periods page, which covers the full picture including timing and what to expect over the first few months of treatment.
This is the most practically important part. If Mounjaro is triggering ovulation in someone who previously wasn't ovulating regularly, the fertility implications are immediate. NHS guidance (including the NHS England weight management injections page) is explicit: women of childbearing potential should use effective contraception during treatment and for a wash-out period before trying to conceive.
There is a specific added consideration for tirzepatide: oral contraceptive pills may be absorbed less reliably in the early weeks of treatment, because Mounjaro slows gastric emptying. For the first four weeks of treatment, and for four weeks after each dose increase, an additional non-oral method (such as condoms) is recommended. Our page on taking Mounjaro while on your period addresses timing and injection scheduling if you have questions about that side of things.
Pregnancy is not recommended while on tirzepatide. This isn't a soft caution. If there is any chance you could be pregnant, that needs to be ruled out before continuing treatment. A GP or pharmacist prescriber is the right person to talk to, not a forum.
Most cycle changes in the first few months of Mounjaro treatment are benign and self-limiting. But certain things warrant prompt medical attention: very heavy or prolonged bleeding, bleeding after the menopause, severe pelvic pain, or a positive pregnancy test. These are not Mounjaro questions at that point, they are gynaecology questions.
For everything else, including a period that arrived earlier than expected or a cycle that has become more regular: raise it with your prescriber at your next review. If you're considering starting treatment and want to understand the full picture first, our tirzepatide overview covers how the medicine works in detail, and our Emerge tirzepatide page goes into further detail about this specific formulation and what to expect from it. The no period on Mounjaro page is worth reading if your concern runs the other way, a cycle that has stopped or become irregular since starting.
If you're weighing up whether treatment is right for you at all, a free consultation with our prescribers is the practical next step. A real clinician (not a form-scoring algorithm) reads every consultation the same day, and if you are planning to travel during treatment, our guide on bringing Mounjaro on a plane is worth reading before you pack. Check your eligibility here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.